Cataract 47 (CTRCT47) Cell Models for Research

Cataract is the leading cause of blindness worldwide, accounting for approximately 51% of global blindness, affecting over 20 million people (WHO, 2023). Cataract 47 (CTRCT47) is a rare, inherited form of congenital or juvenile cataract, with an estimated prevalence of less than 1 in 1,000,000. The condition is characterized by early-onset lens opacification, leading to visual impairment if untreated. Surgical intervention is the primary treatment, but there is a need for better understanding of the molecular mechanisms to develop non-surgical therapies. The 5-year survival is not applicable, as cataract is not life-threatening, but the impact on quality of life is significant, especially in pediatric cases.

CTRCT47 provides an excellent model for studying lens development and protein homeostasis. The disease is monogenic, with mutations in specific genes, making it amenable to precise genetic manipulation. Research focuses on understanding how these mutations disrupt lens fiber cell differentiation, crystallin protein aggregation, and oxidative stress response. Public datasets, such as those from the Human Gene Mutation Database (HGMD) and ClinVar, provide a wealth of mutation data. Open questions include the role of modifier genes and the potential for pharmacological chaperones to prevent protein aggregation.

Although cataract is not a cancer, the term 'carcinogenic' is not applicable. Instead, we describe the major pathogenic pathways:

• • Protein misfolding and aggregation: Mutations in crystallin genes (e.g., CRYAA, CRYAB) lead to protein misfolding and aggregation, causing lens opacity.
• • Oxidative stress: Impaired antioxidant defense mechanisms (e.g., glutathione pathway) contribute to lens damage.
• • Apoptosis of lens epithelial cells: Abnormal apoptosis disrupts lens fiber formation.
• • Disrupted cell-cell communication: Gap junction defects (e.g., connexin mutations) impair nutrient and waste exchange.

Data from ClinVar and COSMIC (not specific to cataract, but lens-related).

Key signaling networks involved in lens development and cataract pathogenesis include:

• • Wnt signaling: Regulates lens epithelial cell proliferation and differentiation.
• • FGF signaling: Essential for lens fiber differentiation.
• • TGF-β signaling: Involved in epithelial-mesenchymal transition (EMT) and fibrosis.
• • Notch signaling: Modulates cell fate decisions.

Key nodes: β-catenin, FGF receptor, SMAD proteins, Notch receptors.

Organoids derived from human pluripotent stem cells can recapitulate lens development and are useful for studying cataract mutations in a 3D context.

Animal models for cataract include:

• • Genetically engineered mouse models (GEMMs): Knock-in mice carrying cataract-associated mutations (e.g., Cryaa R49C) show lens opacity.
• • Induced models: UV irradiation or oxidative stress can induce cataract in rodents.
• • Patient-derived xenografts (PDX): Not applicable for cataract, as it is not a tumor.

CRISPR-based gene editing enables the creation of isogenic cell lines with precise mutations. For example:

• • CRISPR knockout: Knockout of CRYAA in HLE-B3 cells to study loss-of-function effects.
• • CRISPR knock-in: Introduction of a specific point mutation (e.g., CRYAA R49C) to model a patient-specific mutation.

These models are commercially available from various sources, sequence-verified, and can accelerate research by providing consistent and reproducible systems.

Gene-edited cell lines are used to validate the functional impact of cataract-associated genes. For example, knocking out CRYAB in lens epithelial cells can reveal its role in protein chaperone activity and cellular stress response. Knock-in models can confirm the pathogenicity of specific variants.

Isogenic pairs (wild-type vs. mutant) are used for high-throughput screening of compounds that prevent protein aggregation or restore chaperone function. These models can also be used to test drug resistance mechanisms, such as oxidative stress resistance.

CRISPR-based synthetic lethality screens can identify genes that, when silenced, are lethal only in the context of cataract mutations. This can reveal potential therapeutic targets and biomarkers for early diagnosis.